“IL-40: A novel immunoregulatory axis at the crossroads of inflammation, tissue remodeling, and cancer immunity”
Elevated IL-40 in obesity, metabolic syndrome, type 2 diabetes, and allergic diseases further implicates this cytokine in low-grade chronic inflammation and hypersensitivity, and represents a promising immunoregulatory cytokine with diagnostic and therapeutic potential across immune-mediated diseases and cancer.